Abstract
Background: Colon cancer is one of the most common cancers worldwide and has a poor prognosis. Through the analysis of transcriptome and clinical data of colon cancer, an immune gene-set signature was identified by single sample enrichment analysis (ssGSEA) scoring to predict patient survival and discover new therapeutic targets.
Objective: To study the role of immune gene-set signature in colon cancer.
Methods: First, RNASeq and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA). Immune gene-related gene sets were collected from the ImmPort database. Genes and immunological pathways related to prognosis were screened in the training set and integrated for feature selection using random forest. The immune gene-related prognosis model was verified in the entire TCGA test set and GEO validation set and compared with immune cells scores and matrix score.
Results: A total of 1650 prognostic genes and 13 immunological pathways were identified. These genes and pathways are closely related to the development of tumors. 13-immune gene-set signature was established, which is an independent prognostic factor for patients with colon cancer. Risk stratification of samples could be carried out in the training set, test set, and external validation set. The AUC of five-year survival in the training set and validation set is greater than 0.6. Immunosuppression occurs in high-risk samples and compared with published models, riskScore has a better prediction effect.
Conclusion: This study constructed a 13-immune gene-set signature as a new prognostic marker to predict the survival of patients with colon cancer, and provided new diagnostic/prognostic biomarkers and therapeutic targets for colon cancer.
Keywords: Bioinformatics, prognostic markers, TCGA, colon cancer, biomarker, cell mutation.
Combinatorial Chemistry & High Throughput Screening
Title:A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis
Volume: 24 Issue: 8
Author(s): Zhuo Lu, Jin Chen, JiongYi Yan, QiaoMing Liu, Fang Li, WanNa Xiong, Shida Lin, Kai Yu* Jianqin Liang*
Affiliation:
- College of Life Science and Technology, Guangxi University, Nanning, Nanning, 530004,China
- Department of Pharmacy, Guangxi University of Traditional Chinese Medicine, Nanning City, Guangxi Province, 530001,China
Keywords: Bioinformatics, prognostic markers, TCGA, colon cancer, biomarker, cell mutation.
Abstract:
Background: Colon cancer is one of the most common cancers worldwide and has a poor prognosis. Through the analysis of transcriptome and clinical data of colon cancer, an immune gene-set signature was identified by single sample enrichment analysis (ssGSEA) scoring to predict patient survival and discover new therapeutic targets.
Objective: To study the role of immune gene-set signature in colon cancer.
Methods: First, RNASeq and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA). Immune gene-related gene sets were collected from the ImmPort database. Genes and immunological pathways related to prognosis were screened in the training set and integrated for feature selection using random forest. The immune gene-related prognosis model was verified in the entire TCGA test set and GEO validation set and compared with immune cells scores and matrix score.
Results: A total of 1650 prognostic genes and 13 immunological pathways were identified. These genes and pathways are closely related to the development of tumors. 13-immune gene-set signature was established, which is an independent prognostic factor for patients with colon cancer. Risk stratification of samples could be carried out in the training set, test set, and external validation set. The AUC of five-year survival in the training set and validation set is greater than 0.6. Immunosuppression occurs in high-risk samples and compared with published models, riskScore has a better prediction effect.
Conclusion: This study constructed a 13-immune gene-set signature as a new prognostic marker to predict the survival of patients with colon cancer, and provided new diagnostic/prognostic biomarkers and therapeutic targets for colon cancer.
Export Options
About this article
Cite this article as:
Lu Zhuo , Chen Jin , Yan JiongYi , Liu QiaoMing , Li Fang, Xiong WanNa, Lin Shida , Yu Kai *, Liang Jianqin *, A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis, Combinatorial Chemistry & High Throughput Screening 2021; 24 (8) . https://dx.doi.org/10.2174/1386207323666200930104744
DOI https://dx.doi.org/10.2174/1386207323666200930104744 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Emerging trends in diseases mechanisms, noble drug targets and therapeutic strategies: focus on immunological and inflammatory disorders
Recently infectious and inflammatory diseases have been a key concern worldwide due to tremendous morbidity and mortality world Wide. Recent, nCOVID-9 pandemic is a good example for the emerging infectious disease outbreak. The world is facing many emerging and re-emerging diseases out breaks at present however, there is huge lack ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Scope of the Thematic Issue: Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute force experimentation, which can be time-consuming and resource-intensive. Spectral Graph Theory, a branch of mathematics dealing with the properties of graphs in relation to the ...read more
Integrating Network Pharmacology and Traditional Medicine: A New Perspective in Drug Mechanism Research
Network pharmacology is a network construction and network topology analysis strategy that combines pharmacology and pharmacodynamics. In recent years, network pharmacology has emerged as a powerful tool that can be integrated with pharmacology. Natural products commonly function in multicomponent, multitarget, and multipathway systems. Some examples encompass Ayurveda, traditional Chinese medicines ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plant Sterols and Stanols as Cholesterol-Lowering Ingredients in Functional Foods
Recent Patents on Food, Nutrition & Agriculture <i>In Silico</i> Structural and Functional Analysis of <i>Bacillus</i> Uricases
Current Proteomics Effect of Substituted Benzimidazoles and Somatostatin Analogs on the Vitality of Tumor Cell Lines and on the Oxidative Burst of Phagocytes
Letters in Drug Design & Discovery Mechanisms of Cytotoxicity of Anticancer Titanocenes
Anti-Cancer Agents in Medicinal Chemistry A Century of Thioxanthones: Through Synthesis and Biological Applications
Current Medicinal Chemistry Unveiling Cancer in IBD: Screening Colonoscopy or Chromoendoscopy
Current Drug Targets Design, Synthesis and Biological Evaluation of Palladium (II) Complexes with 1-(substituted benzyl) azetidine-3,3-dicarboxylates as Leaving Group
Medicinal Chemistry Blood Immunoglobulins, Complement and TNF Receptor Following Minimally Invasive Surgery in Patients Undergoing Pulmonary Lobectomy
Current Metabolomics Zinc Homeostasis-regulating Proteins: New Drug Targets for Triggering Cell Fate
Current Drug Targets DNA Copy Number Profiles Correlate with Outcome in Colorectal Cancer Patients Treated with Fluoropyrimidine/Antifolate-based Regimens
Current Drug Metabolism An Overview of Olive Oil Biomolecules
Current Biotechnology Hydroxylated Dendrimer-Stabilized Gold and Silver Nanoparticles: Spontaneous Formation, Characterization, and Surface Properties
Current Nanoscience Fluorescence Studies of Anti-Cancer Drugs - Analytical and Biomedical Applications
Current Drug Targets Development and Validation of a New Method to Quantify Pilocarpine in Tablets by HPLC-DAD
Current Pharmaceutical Analysis Synthesis of 5-Arylidene Barbiturates: A Novel Class of DPPH Radical Scavengers
Letters in Drug Design & Discovery Alkannins and Shikonins: A New Class of Wound Healing Agents
Current Medicinal Chemistry Differential Serum Level of Specific Haptoglobin Isoforms in Small Cell Lung Cancer
Current Proteomics Overexpression and Characterization of the C-Terminal Domain of Human SIVA1: A Proapoptotic Factor and Cytoskeleton Binding Protein
Protein & Peptide Letters Cancer and Treatment Modalities
Current Cancer Therapy Reviews Chemistry, Stability and Bioavailability of Resveratrol
Medicinal Chemistry